This is a routine insider sale for tax or diversification purposes with no material read-through. Monitor for any subsequent Form 4 filings to confirm execution, but no trading action is warranted based on this notice alone.
Price Chart
Executive Summary
Officer Stephen Michael Kelsey filed a Form 144 notice of intent to sell 4,071 shares of Revolution Medicines common stock, valued at approximately $626,000. The shares were acquired through restricted stock unit grants in 2023-2025, and the sale appears to be a routine diversification or tax-related transaction. Given the negligible size relative to RVMD's $32.7B market cap, this filing carries no material signal for the stock.
Key Facts
- Insider Stephen Michael Kelsey (officer) filed Form 144 to sell 4,071 shares of RVMD common stock.
- Estimated market value of proposed sale: ~$626,405 based on filing date.
- Shares were acquired via RSU grants on 03/01/2023, 03/01/2024, and 03/01/2025 for services rendered.
- Prior sale of 4,302 shares occurred on 03/17/2026 for ~$427,965.
- Filing represents intent to sell; actual sale may not occur.
Financial Impact
Proposed sale of 4,071 shares (~$626K) is immaterial relative to $32.7B market cap (0.002%).
Risk Factors
- Insider may still execute the sale, but the amount is too small to signal negative sentiment.
- No indication of broader insider selling pattern; prior 30-day insider activity totaled only $297K in sells.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001462808-26-000002 |
| Document: 0001462808-26-000002-index.html | 0001462808-26-000002 |
| Document: 0001462808-26-000002.txt | 0001462808-26-000002 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 16d ago | 144 | $195.92 $190.74 | ▼ −2.64% | ▼ −5.21% | $206.29 (+5.29%) |
Sep 15, 2026 16d ago | 144 | $195.92 $190.74 | ▼ −2.64% | ▼ −5.21% | $206.29 (+5.29%) |
Sep 15, 2026 17d ago | Insider Cluster | $204.86 $190.95 | ▼ −6.79% | ▼ −7.61% | $206.29 (+0.70%) |
Sep 14, 2026 17d ago | Insider Cluster | $204.86 $192.86 | ▼ −5.86% | ▼ −7.98% | $206.29 (+0.70%) |
Aug 26, 2026 5w ago | 8-K | $215.44 $209.23 | ▼ −2.88% | ▼ −2.76% | $206.29 (−4.25%) |
Aug 26, 2026 5w ago | Press Release | $215.44 $209.23 | ▼ −2.88% | ▼ −2.76% | $206.29 (−4.25%) |
Aug 25, 2026 5w ago | Insider Cluster | $211.38 $209.87 | ▼ −0.71% | ▼ −0.18% | $206.29 (−2.41%) |
Jul 2, 2026 13w ago | Press Release | $189.24 $191.13 | ▲ +1.00% | ▲ +0.07% | $206.29 (+9.01%) |
Jul 1, 2026 13w ago | Insider Cluster | $187.51 $190.46 | ▲ +1.57% | ▲ +1.31% | $206.29 (+10.02%) |
Jun 22, 2026 14w ago | 8-K | $165.81 $192.62 | ▲ +16.17% | ▲ +16.62% | $206.29 (+24.41%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access